TLG Capital

TLG Capital is an award-winning private investment firm dedicated to empowering frontier market entrepreneurs, with a focus on opportunities in Sub-Saharan Africa (SSA).TLG firmly believes that impact creation is crucial to sustained financial success. They are committed to tackling persistent challenges and better directing resources towards improving the lives for some of the world’s most vulnerable people. Their investments have had a significantly social, environmental and development impact across Sub-Saharan Africa.TLG Africa Limited is a permanent capital investment vehicle focusing on equity opportunities in Sub-Saharan Africa (SSA). TLG Africa invests in sectors underpinned by the ‘rise of the African consumer’, such as: healthcare, finance, consumer goods and real estate. These investments include direct minority/majority stake investments, secondary opportunities and distressed fund restructurings. TLG Africa always seeks board representation, along with other minority protections. Notable investments include WHO pre-approved pharmaceutical plant QCIL (Uganda) and healthcare facilities in West Africa. In recognition for their efforts, their deals have won multiple awards including ‘Landmark Deal of the Decade’ in 2012 and 'Frontier Deal of the Year' in 2014 from Private Equity Africa.

Frédéric BIDET

COO

Dominic Clive

Principal

Isha Doshi

Partner and CFO

Zhi Yong Heng

Principal

Amanda Kabagambe

Partner and Head of East Africa

Zain Latif

Principal, CEO and Founder

Isaac Marshall

Investment Professional

Johnnie Puxley

Investment Professional

Saad Sheikh

Principal, Investments

Zahid, Auraib

Principal, Investments

Past deals in Uganda

BAJ Service Stations

Debt Financing in 2017
BAJ operating fuel stations across Uganda since 2002 and consolidated the business under the BAJ brand name in 2016. The business owns and operates 6 fuel stations across Uganda with sites in Entebbe, Luwero, Kabale and Kayunga. BAJ continues to explore opportunities to grow organically through acquisition of distressed players in the market or constructing new stations.

Cipla Quality Chemical Industries

Private Equity Round in 2009
Cipla Quality Chemical Industries Limited, based in Kampala, Uganda, is a pharmaceutical manufacturing company specializing in the production of essential medications. The company focuses on anti-retroviral drugs to treat HIV/AIDS, as well as Artemisinin-based Combination Therapies (ACTs) for malaria and medicines for hepatitis. By providing these critical therapies, CiplaQCIL supports healthcare professionals in their efforts to effectively treat patients and improve health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.